-transparent.png){kind=logo}
One hundred and twenty-six patients with definite or classical rheumatoid arthritis admitted to hospital between 1965 and 1974 for cytotoxic therapy were studied for the presence and type of malignant disease. Each of the cytotoxic treated patients was age and sex matched to a rheumatoid arthritis patient admitted to hospital during the same years but who did not receive cytotoxic therapy. There was no increase in malignancy in the cytotoxic treated group over the control group.
Related Publications
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
May 1972,
Annals of the rheumatic diseases,
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
May 1968,
The Medical clinics of North America,
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
May 1993,
British journal of rheumatology,
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
August 2013,
Annals of the rheumatic diseases,
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
January 1976,
The Journal of rheumatology,
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
June 1984,
Journal of hand surgery (Edinburgh, Scotland),
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
April 1976,
Lancet (London, England),
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
January 2000,
Journal of gastroenterology,
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
May 1985,
Annals of the rheumatic diseases,
A B Kirsner, and
S J Farber, and
R P Sheon, and
R I Finkel
February 2015,
Current rheumatology reports,
